Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) ROIC %: 14.81% (As of Mar. 2026)


SHSE:605033 Shaanxi Meibang Pharmaceutical Group Co Ltd SHSE:605033
81 GF Score
Price ¥17.37
GF Value ¥22.13
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Shaanxi Meibang Pharmaceutical Group Co ROIC %?

Shaanxi Meibang Pharmaceutical Group Co SHSE:605033 +1.82% 81 ROIC % is 14.81% as of Mar. 2026. GuruFocus rates SHSE:605033 with a GF Score™ of 81/100 and a GF Value™ of ¥22.13 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Shaanxi Meibang Pharmaceutical Group Co's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2026 was 14.81%.

As of today (2026-07-12), Shaanxi Meibang Pharmaceutical Group Co's WACC % is 8.88%. Shaanxi Meibang Pharmaceutical Group Co's ROIC % is 6.21% (calculated using TTM income statement data). Shaanxi Meibang Pharmaceutical Group Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Shaanxi Meibang Pharmaceutical Group Co  (SHSE:605033) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Shaanxi Meibang Pharmaceutical Group Co's WACC % is 8.88%. Shaanxi Meibang Pharmaceutical Group Co's ROIC % is 6.21% (calculated using TTM income statement data). Shaanxi Meibang Pharmaceutical Group Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Shaanxi Meibang Pharmaceutical Group Co ROIC % Related Terms


Shaanxi Meibang Pharmaceutical Group Co ROIC % Historical Data

* Premium members only.

The historical data trend for Shaanxi Meibang Pharmaceutical Group Co's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shaanxi Meibang Pharmaceutical Group Co ROIC % Chart

Shaanxi Meibang Pharmaceutical Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROIC %
Get a 7-Day Free Trial Premium Member Only 18.77 15.79 5.75 3.62 5.36

Shaanxi Meibang Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.98 3.05 0.00 8.15 14.81

SHSE:605033 vs CTVA, CF, MOS: ROIC % Comparison

For the Agricultural Inputs subindustry, Shaanxi Meibang Pharmaceutical Group Co's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shaanxi Meibang Pharmaceutical Group Co ROIC % vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Shaanxi Meibang Pharmaceutical Group Co's ROIC % distribution charts can be found below:

* The bar in red indicates where Shaanxi Meibang Pharmaceutical Group Co's ROIC % falls into.


SHSE:605033
81GF Score
Shaanxi Meibang Pharmaceutical Group Co Ltd SHSE:605033
ROIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shaanxi Meibang Pharmaceutical Group Co ROIC % Calculation

Shaanxi Meibang Pharmaceutical Group Co's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROIC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=64.783 * ( 1 - 7.08% )/( (1018.761 + 1229.164)/ 2 )
=60.1963636/1123.9625
=5.36 %

where

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1862.032 - 362.816 - ( 656.33 - max(0, 616.258 - 1096.713+656.33))
=1018.761

Invested Capital(A: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2068.131 - 387.1 - ( 764.112 - max(0, 705.261 - 1157.128+764.112))
=1229.164

Shaanxi Meibang Pharmaceutical Group Co's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Mar. 2026 is calculated as:

ROIC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=212.496 * ( 1 - 20.75% )/( (1229.164 + 1044.722)/ 2 )
=168.40308/1136.943
=14.81 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2068.131 - 387.1 - ( 764.112 - max(0, 705.261 - 1157.128+764.112))
=1229.164

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1969.988 - 342.271 - ( 582.995 - max(0, 451.189 - 1077.436+582.995))
=1044.722

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of 14.81% mean?
Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) has a ROIC % of 14.81% as of Mar. 2026. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors.
Is Shaanxi Meibang Pharmaceutical Group Co's ROIC % too high?
Shaanxi Meibang Pharmaceutical Group Co's current ROIC % is 14.81%. The Agriculture industry median ROIC % is 5.48. Shaanxi Meibang Pharmaceutical Group Co's value of 14.81% is 170.5% above this industry median. Overall, Shaanxi Meibang Pharmaceutical Group Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shaanxi Meibang Pharmaceutical Group Co's ROIC % compare to CTVA and CF?
Shaanxi Meibang Pharmaceutical Group Co's ROIC % of 14.81% can be compared against companies in the Agriculture industry. The industry median ROIC % is 5.48. Shaanxi Meibang Pharmaceutical Group Co's value of 14.81% is 170.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for an Agriculture company?
The median ROIC % among Agriculture companies is 5.48, based on 256 companies in the industry. Companies in the top quartile (top 25%) have a ROIC % significantly above this median, while those in the bottom quartile fall well below. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shaanxi Meibang Pharmaceutical Group Co's current ROIC % of 14.81% is 170.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. For the Agriculture industry, the median ROIC % is 5.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shaanxi Meibang Pharmaceutical Group Co's current ROIC % is 14.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shaanxi Meibang Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥22.13, compared to a current price of ¥17.37 — trading 21.5% below its estimated fair value. The current ROIC % is 14.81% and 170.5% above the Agriculture industry median of 5.48. Shaanxi Meibang Pharmaceutical Group Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033), the current ROIC % is 14.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) Overvalued in 2026?

Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥17.37 is trading 21.5% below its estimated GF Value™ of ¥22.13. GuruFocus considers Shaanxi Meibang Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:605033:

  • ROIC %: 14.81%
  • GF Value™: ¥22.13 vs. price of ¥17.37 (21.5% below fair value)
  • GF Score™: 81/100 with 3 warning signs
  • Industry Position: 170.5% above the Agriculture median

No single metric tells the full story. See the SHSE:605033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shaanxi Meibang Pharmaceutical Group Co Business Description

Address High-tech Industrial Development Zone, Pucheng County, Shaanxi Province, Weinan, CHN, 715500
Shaanxi Meibang Pharmaceutical Group Co Ltd is engaged in the research and development, production and sales of pesticide formulations.
81GF Score

Get the complete analysis for SHSE:605033

ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.37
Price
¥22.13
GF Value